Literature DB >> 21605704

Transmission probabilities and durations of immunity for three pathogenic group B Streptococcus serotypes.

Bethany Percha1, M E J Newman, Betsy Foxman.   

Abstract

Group B Streptococcus (GBS) remains a major cause of neonatal sepsis and is an emerging cause of invasive bacterial infections. The 9 known serotypes vary in virulence, and there is little cross-immunity. Key parameters for planning an effective vaccination strategy, such as average length of immunity and transmission probabilities by serotype, are unknown. We simulated GBS spread in a population using a computational model with parameters derived from studies of GBS sexual transmission in a college dormitory. Here we provide estimates of the duration of immunity relative to the transmission probabilities for the 3 GBS serotypes most associated with invasive disease: Ia, III, and V. We also place upper limits on the durations of immunity for serotype Ia (570 days), III (1125 days) and V (260 days). Better transmission estimates are required to establish the epidemiological parameters of GBS infection and determine the best vaccination strategies to prevent GBS disease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605704      PMCID: PMC3391980          DOI: 10.1016/j.meegid.2011.05.005

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  28 in total

1.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

2.  Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study.

Authors:  Sandra J Bliss; Shannon D Manning; Patricia Tallman; Carol J Baker; Mark D Pearlman; Carl F Marrs; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2001-12-05       Impact factor: 9.079

3.  Immunogenicity of polysaccharides from type III, group B Streptococcus.

Authors:  C J Baker; M S Edwards; D L Kasper
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.

Authors:  Q Cheng; B Carlson; S Pillai; R Eby; L Edwards; S B Olmsted; P Cleary
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women.

Authors:  Leslie A Meyn; Donna M Moore; Sharon L Hillier; Marijane A Krohn
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

6.  Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

Authors:  C J Baker; M A Rench; M S Edwards; R J Carpenter; B M Hays; D L Kasper
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

7.  Conjugate vaccines against group B Streptococcus types IV and VII.

Authors:  Lawrence C Paoletti; Dennis L Kasper
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

8.  Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women.

Authors:  Shannon D Manning; Katie Neighbors; Patricia A Tallman; Brenda Gillespie; Carl F Marrs; Stephanie M Borchardt; Carol J Baker; Mark D Pearlman; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2004-07-16       Impact factor: 9.079

9.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission.

Authors:  K M Boyer; C A Gadzala; P D Kelly; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

10.  Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.

Authors:  Mashudu Madzivhandila; Peter V Adrian; Clare L Cutland; Locadiah Kuwanda; Stephanie J Schrag; Shabir A Madhi
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

View more
  1 in total

1.  Molecular typing and prevalence of antibiotic resistance and virulence genes in Streptococcus agalactiae isolated from Chinese dairy cows with clinical mastitis.

Authors:  Guangli Han; Baohai Zhang; Zidan Luo; Biao Lu; Zhengzhong Luo; Jieru Zhang; Yin Wang; Yan Luo; Zexiao Yang; Liuhong Shen; Shumin Yu; Suizhong Cao; Xueping Yao
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.